Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation
US-2026008859-A1 · Jan 8, 2026 · US
Galderma Holding S A holds 10 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 10 |
| Recent patents | 8 |
| First publication | Jul 20, 2021 |
| Latest publication | Jan 8, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026008859-A1 · Jan 8, 2026 · US
US-12416634-B2 · Sep 16, 2025 · US
US-D1043977-S · Sep 24, 2024 · US
US-2024141050-A1 · May 2, 2024 · US
US-11939433-B2 · Mar 26, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026008859-A1 · Jan 8, 2026 · US
US-12416634-B2 · Sep 16, 2025 · US
US-D1043977-S · Sep 24, 2024 · US
US-2024141050-A1 · May 2, 2024 · US
US-11939433-B2 · Mar 26, 2024 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 9 |
| Human Necessities | 7 |
| Physics | 3 |
Answers are generated from the same data shown on this page.